Carson Wealth (CWM LLC)
ELDN icon

Carson Wealth (CWM LLC)’s Eledon Pharmaceuticals ELDN Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio ELDN Stock Details ELDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$30.6K Buy
9,944
+7,933
+394% +$18.7K ﹤0.01% 4146
2025
Q4 		$3K Buy
2,011
+1,923
+2,185% +$4.57K ﹤0.01% 4966
2025
Q3 		$0 Buy
+88
New +$257 ﹤0.01% 5341

Other funds holding ELDN

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $712M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
CCM
Catalio Capital Management New York $479M AUM 140.7% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return

Carson Wealth (CWM LLC)'s ELDN Position: Q1 2026 in Review

Carson Wealth (CWM LLC) increased its Eledon Pharmaceuticals (ELDN) stake by 394% in Q1 2026, buying an estimated $18.7K and bringing the position to 9,944 shares worth $30.6K. The position accounts for ﹤0.01% of the portfolio, ranked #4146.

Carson Wealth (CWM LLC) first reported a position in ELDN in Q3 2025 and has held it in 3 quarters since. 121 funds tracked by Wall St. Rank hold ELDN as of Q1 2026.

  • Carson Wealth (CWM LLC) held 9,944 shares of Eledon Pharmaceuticals worth $30.6K as of Q1 2026.
  • Carson Wealth (CWM LLC) bought 7,933 Eledon Pharmaceuticals shares in Q1 2026, an estimated $18.7K.
  • Eledon Pharmaceuticals made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #4146 holding.
  • Carson Wealth (CWM LLC) first reported a position in Eledon Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • 121 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.